Assessment of the cytolytic potential of a multivirus-targeted T cell therapy using a vital dye-based, flow cytometric assay by Kiriakos Koukoulias, Penelope G. Papayanni, Julia Jones, Manik Kuvalekar, Ayumi Watanabe, Yovana Velazquez, Sarah Gilmore, Anastasia Papadopoulou, Ann M. Leen, Spyridoula Vasileiou

Get full text

A dual-luciferase bioluminescence system for the assessment of cellular therapies by Alejandro G. Torres Chavez, Mary K. McKenna, Kishore Balasubramanian, Lisa Riffle, Nimit L. Patel, Joseph D. Kalen, Brad St. Croix, Ann M. Leen, Pradip Bajgain

Get full text

Rapid generation of multivirus-specific T lymphocytes for the prevention and treatment of respiratory viral infections by Spyridoula Vasileiou, Anne M. Turney, Manik Kuvalekar, Shivani S. Mukhi, Ayumi Watanabe, Premal Lulla, Carlos A. Ramos, Swati Naik, Juan F. Vera, Ifigeneia Tzannou, Ann M. Leen

Get full text

Longitudinal analysis of the evolution of cellular immunity to SARS-CoV-2 induced by infection and vaccination by Spyridoula Vasileiou, Manik Kuvalekar, Yovana Velazquez, Ayumi Watanabe, Mansi Narula, Aster G. Workineh, Matthew French-Kim, Alejandro Torres Chavez, Sarah Gilmore, Cliona M. Rooney, Ann M. Leen

Get full text

Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients by Spyridoula Vasileiou, LaQuisa Hill, Manik Kuvalekar, Aster G. Workineh, Ayumi Watanabe, Yovana Velazquez, Suhasini Lulla, Kimberly Mooney, Natalia Lapteva, Bambi J. Grilley, Helen E. Heslop, Cliona M. Rooney, Malcolm K. Brenner, Todd N. Eagar, George Carrum, Kevin A. Grimes, Ann M. Leen, Premal Lulla

Get full text